TuMorMatch T-Cell Lymphomas

TuMorMatch: T-Cell & NK-Cell Lymphoma Panel

Toggle markers ON (+) or OFF (-) to evaluate immature, mature, TFH, cytotoxic, and cutaneous T-cell neoplasms.

🔬 Staining Patterns:
  • TdT / BCL6 / ALK (nuclear component) / Ki-67: Nuclear
  • CXCL13 / Cytotoxic Granules (TIA-1, Granzyme B, Perforin) / cyCD3: Cytoplasmic
  • CD2 / CD4 / CD5 / CD7 / CD8 / CD10 / CD1a / CD30 / CD34 / CD56 / CD99 / EMA / PD1 / ALK: Membranous / Cytoplasmic
TdT (Precursor)
OFF
Cytoplasmic CD3
OFF
Membranous CD3
OFF
CD1a / CD34 / CD99
OFF
CD4 Positivity
OFF
CD8 Positivity
OFF
Aberrant Loss (CD5/CD7/CD2)
OFF
CD30 (Strong/Uniform)
OFF
ALK Protein
OFF
EMA
OFF
TFH Markers (PD1/CD10/CXCL13/BCL6)
OFF
CD56 (NCAM)
OFF
Cytotoxic Granules (TIA1/GrB/Perf)
OFF
High Ki-67 Index
OFF

Diagnostic Possibilities Active Markers: None

Disclaimer: Diagnostic probabilities are estimates based on characteristic immunophenotypic criteria. TumorMatch serves as an educational and decision support tool. Clinical correlation (e.g., skin biopsy vs nodal vs extranodal nasal distribution), morphology, and molecular studies (TCR gene rearrangement, EBV-ISER) are mandatory for definitive subtyping under WHO/ICC guidelines.